John B. Harlow Jr.
Chief Commercial Officer; President and COO · 2 filings · Latest: Sep 29, 2026
Esperion Therapeutics, Inc.
Larimar Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
Chief Commercial Officer; President and COO · 2 filings · Latest: Sep 29, 2026
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|